Results 191 to 200 of about 53,094 (317)

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley   +1 more source

Radiomics-based explainable artificial intelligence to predict treatment response following lung stereotactic body radiation therapy. [PDF]

open access: yesBr J Radiol
Cilla S   +9 more
europepmc   +1 more source

Verification of Acuros XB dose algorithm using 3D printed low‐density phantoms for clinical photon beams [PDF]

open access: yes, 2018
Khan, Rao   +4 more
core   +2 more sources

Pathologic Outcomes of Systemic Therapy Followed By Stereotactic Body Radiation Therapy for Pancreatic Cancer in a Novel Lateral Decubitus Treatment Position [PDF]

open access: bronze, 2019
Ethan Y. Song   +9 more
openalex   +1 more source

Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Interventional radiology (IR) is a rapidly evolving medical field that combines advanced imaging with minimally invasive techniques for both diagnosis and treatment. Interventional oncology (IO), a subspecialty of IR, focuses on the minimally invasive, image‐guided intervention for cancer and cancer‐related conditions.
Mohamed E. Abdelsalam   +9 more
wiley   +1 more source

Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases

open access: green, 2017
Will Jackson   +9 more
openalex   +2 more sources

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequencing. The 2025 Advanced Urologic Cancer Consensus Conference was convened to establish evidence‐based expert consensus recommendations for optimal management.
Rana R. McKay   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy